Business booming for private German hospital chain:
This article was originally published in Clinica
The HELIOS clinics, a private hospitals chain, last week announced an increased turnover of 33% to E563 million ($499 million) for 2001. The HELIOS group acquired three hospitals during 2001, bringing its total number of clinics to 21 and increasing its number of hospital beds by 30% to 6,145. During April last year it gained a majority share in HELIOS Clinic Erfurt, making this the first time a hospital chain had successfully taken a German maximum care hospital into the private sector. In August the group also acquired a hospital in Kitzbuhel, Austria, and has since said that it intends to search for more acquisitions there.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.